Anomalies resembling Pelger–Huët anomaly that are acquired rather than congenital have been described as pseudo Pelger–Huët anomaly. These can develop in the course of
acute myelogenous leukemia or
chronic myelogenous leukemia and in
myelodysplastic syndrome. It has also been described in Filovirus disease. In patients with these conditions, the pseudo–Pelger–Huët cells tend to appear late in the disease and often appear after considerable chemotherapy has been administered. The morphologic changes have also been described in
myxedema associated with
panhypopituitarism,
vitamin B12 and
folate deficiency,
multiple myeloma, enteroviral infections,
malaria,
muscular dystrophy,
leukemoid reaction secondary to metastases to the bone marrow, and drug sensitivity, sulfa and
valproate toxicities are examples. In some of these conditions, especially the drug-induced cases, it is important to differentiate between Pelger–Huët anomaly and pseudo-Pelger–Huët to prevent the need for further unnecessary testing for cancer. Peripheral blood smear shows a predominance of neutrophils with bilobed nuclei which are composed of two nuclear masses connected with a thin filament of chromatin. It resembles the pince-nez glasses, so it is often referred to as
pince-nez appearance. Usually the congenital form is not associated with thrombocytopenia and leukopenia, so if these features are present more detailed search for myelodysplasia is warranted, as pseudo-Pelger–Huët anomaly can be an early feature of myelodysplasia. In 2022, Reilly et al. showed that loss of LMNB1, the gene encoding lamin B1, is necessary and sufficient to cause pseudo-Pelger-Huet anomaly in neutrophils. Myeloid malignancies with pseudo-Pelger-Huet neutrophils typically have deletion of chromosome 5q, which contains the LMNB1 gene. ==References==